Oriental Aromatics Ltd
Q2 FY25 Earnings Call Analysis
Chemicals & Petrochemicals
fundraise: Nocapex: Norevenue: Category 3margin: Category 3orderbook: No information
π°fundraise
Any current/future new fundraising through debt or equity?
- Currently, there is no specific mention of any new fundraising plans through debt or equity.
- Management plans to "go slow" on CAPEX and take a pause to evaluate ongoing investments before committing to new ones.
- They remain open to new opportunities based on ideas from their creative team or customer interactions.
- The company has sufficient leverage on the balance sheet, available land, and environmental clearance to undertake future investments if needed.
- No firm plans are "on the table" or "off the table" as of now, indicating a flexible approach towards future funding depending on opportunities.
- Past CAPEX cycles have seen postponements and optimizations, particularly at the Mahad multipurpose plant, suggesting prudent capital management.
ποΈcapex
Any current/future capex/capital investment/strategic investment?
- The company plans to **go slow on CAPEX in the current year**, opting to **pause and evaluate ongoing investments** before moving forward.
- There is **no firm CAPEX plan currently on the table**, but management remains **open to opportunities** identified by their creative team or through global customer interactions.
- The **balance sheet and P&L have leverage**, and the company owns **land and environmental clearances (EC)** to support future investments.
- Past CAPEX includes a **brownfield project at Baroda** (hydrogenation facility) and a **greenfield expansion at Mahad** (single product plant Phase 1).
- Some previously planned CAPEX projects, such as a **multi-purpose plant at Mahad, have been postponed or optimized**, leading to better cost control.
- Management is **open but currently not inclined towards CDMO/CMO tie-ups**; prefer to make in-house to ensure sustainability.
In summary, current approach is cautious with a pause but strategic openness to new investments.
πrevenue
Future growth expectations in sales/revenue/volumes?
- The company anticipates steady growth supported by strong customer trust and a diversified portfolio.
- Group sales volume grew 4% YoY in Q1 FY26, driven by hydrogenation plant output and initial sales from Mahad facility.
- They expect the Mahad facility ramp-up to continue positively impacting revenue in coming quarters.
- EBITDA margin guidance remains at 8%-10%, with expectations to cross this range over time.
- Incremental sales from recent INR 200+ crore CAPEX are expected to yield 1.7x asset turnover over 2-3 years.
- Broadly, utilization of non-Mahad plants is optimal at 75%-80%, with Mahad plant capacity ramping from 20%-30% towards target.
- The Indian marketβs Q2 and Q3 festive/winter season drives higher demand, especially for camphor, fragrances, and aroma chemicals.
- Long-term confidence is high due to over 40 new globally accepted products running at 70%-80% capacity, supporting positive volume and revenue growth.
πmargin
Future growth expectations in earnings/operating earnings/profits/EPS?
- The company expects incremental sales from recent investments to be about 1.7x over 2 to 3 years.
- EBITDA margin guidance is maintained at 8% to 10%, with an aim to exceed this over time.
- Mahad plant is currently ramping up production and expected to achieve positive EBITDA in coming quarters, improving overall profitability.
- Existing plants are operating at 75%-80% capacity, indicating potential for stable revenues.
- Focus on launching new products and gaining global acceptance (40+ new products launched in last 5 years running at 70%-80% capacity).
- Management intends to be cautious with CAPEX, focusing on optimizing current investments before new expansions.
- Revenue growth of about 1.7x is linked to asset turnover expectations from new capacities.
- Profitability and margin improvements expected as new plants stabilize and market acceptance grows.
πorderbook
Current/ Expected Orderbook/ Pending Orders?
- The transcript does not explicitly mention the current or expected order book or pending orders for Oriental Aromatics Limited.
- However, the company indicates confidence in its product launches and ongoing engagements, mentioning over 40 products launched in the last 5 years, all globally accepted and running at 70% to 80% plant capacity.
- They highlight challenges in predicting exact timelines due to factors like RFQ (Request for Quotation) windows and customer engagement cycles.
- The management is positive about future opportunities but cautious about exact numbers or timelines for orders.
- The company also emphasizes ongoing customer trust and engagement, especially in fragrance and aroma chemicals, suggesting a steady inflow of business but no specific order backlog figures disclosed.
- They are watching market conditions and supply chain dynamics closely to evaluate CAPEX and related order fulfillment capabilities.
